The global Autoimmune Drugs market was valued at US$ 2242.3 million in 2023 and is anticipated to reach US$ 2949.9 million by 2030, witnessing a CAGR of 4.0% during the forecast period 2024-2030.

Autoimmune Drugs Market

Abnormal immune responses of the innate immune system can cause autoimmune diseases, which can damage body tissues and lead to abnormal organ functions. Immunological complications due to physiological processes within the human body lead to autoimmune diseases. These diseases are characterized by chronic inflammatory processes that activate the innate immune system and the production of antibodies that destroy host tissues. These inflammatory processes can be caused by genetic or environmental factors or infections.

North American market for Autoimmune Drugs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Autoimmune Drugs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global manufacturers of Autoimmune Drugs include Eli Lilly, GSK, AbbVie, Johnson & Johnson, Biogen, Amgen, Pfizer, Roche and Baxter, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Autoimmune Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Autoimmune Drugs.

Report Scope

The Autoimmune Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Autoimmune Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Autoimmune Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Autoimmune Drugs Market Report

Report Metric	Details
Report Name	Autoimmune Drugs Market
Accounted market size in 2023	US$ 2242.3 million
Forecasted market size in 2030	US$ 2949.9 million
CAGR	4.0%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Rheumatoid Arthritis (RA) Multiple Sclerosis (MS) Psoriasis Inflammatory Bowel Disease (IBD) Ankylosing Spondylitis (AS) Systemic Lupus Erythematosus (SLE)
Segment by Application	Hospitals Homecare Specialty Clinics
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Eli Lilly, GSK, AbbVie, Johnson & Johnson, Biogen, Amgen, Pfizer, Roche, Baxter
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Autoimmune Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Autoimmune Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Autoimmune Drugs Market growing?

Ans: The Autoimmune Drugs Market witnessing a CAGR of 4.0% during the forecast period 2024-2030.

What is the Autoimmune Drugs Market size in 2030?

Ans: The Autoimmune Drugs Market size in 2030 will be US$ 2949.9 million.

Who are the main players in the Autoimmune Drugs Market report?

Ans: The main players in the Autoimmune Drugs Market are Eli Lilly, GSK, AbbVie, Johnson & Johnson, Biogen, Amgen, Pfizer, Roche, Baxter

What are the Application segmentation covered in the Autoimmune Drugs Market report?

Ans: The Applications covered in the Autoimmune Drugs Market report are Hospitals, Homecare, Specialty Clinics

What are the Type segmentation covered in the Autoimmune Drugs Market report?

Ans: The Types covered in the Autoimmune Drugs Market report are Rheumatoid Arthritis (RA), Multiple Sclerosis (MS), Psoriasis, Inflammatory Bowel Disease (IBD), Ankylosing Spondylitis (AS), Systemic Lupus Erythematosus (SLE)

1 Autoimmune Drugs Market Overview

1.1 Product Overview and Scope of Autoimmune Drugs

1.2 Autoimmune Drugs Segment by Type

1.2.1 Global Autoimmune Drugs Market Value Comparison by Type (2024-2030)

1.2.2 Rheumatoid Arthritis (RA)

1.2.3 Multiple Sclerosis (MS)

1.2.4 Psoriasis

1.2.5 Inflammatory Bowel Disease (IBD)

1.2.6 Ankylosing Spondylitis (AS)

1.2.7 Systemic Lupus Erythematosus (SLE)

1.3 Autoimmune Drugs Segment by Application

1.3.1 Global Autoimmune Drugs Market Value by Application: (2024-2030)

1.3.2 Hospitals

1.3.3 Homecare

1.3.4 Specialty Clinics

1.4 Global Autoimmune Drugs Market Size Estimates and Forecasts

1.4.1 Global Autoimmune Drugs Revenue 2019-2030

1.4.2 Global Autoimmune Drugs Sales 2019-2030

1.4.3 Global Autoimmune Drugs Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Autoimmune Drugs Market Competition by Manufacturers

2.1 Global Autoimmune Drugs Sales Market Share by Manufacturers (2019-2024)

2.2 Global Autoimmune Drugs Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Autoimmune Drugs Average Price by Manufacturers (2019-2024)

2.4 Global Autoimmune Drugs Industry Ranking 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Autoimmune Drugs, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Autoimmune Drugs, Product Type & Application

2.7 Autoimmune Drugs Market Competitive Situation and Trends

2.7.1 Autoimmune Drugs Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Autoimmune Drugs Players Market Share by Revenue

2.7.3 Global Autoimmune Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Autoimmune Drugs Retrospective Market Scenario by Region

3.1 Global Autoimmune Drugs Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Autoimmune Drugs Global Autoimmune Drugs Sales by Region: 2019-2030

3.2.1 Global Autoimmune Drugs Sales by Region: 2019-2024

3.2.2 Global Autoimmune Drugs Sales by Region: 2025-2030

3.3 Global Autoimmune Drugs Global Autoimmune Drugs Revenue by Region: 2019-2030

3.3.1 Global Autoimmune Drugs Revenue by Region: 2019-2024

3.3.2 Global Autoimmune Drugs Revenue by Region: 2025-2030

3.4 North America Autoimmune Drugs Market Facts & Figures by Country

3.4.1 North America Autoimmune Drugs Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Autoimmune Drugs Sales by Country (2019-2030)

3.4.3 North America Autoimmune Drugs Revenue by Country (2019-2030)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Autoimmune Drugs Market Facts & Figures by Country

3.5.1 Europe Autoimmune Drugs Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Autoimmune Drugs Sales by Country (2019-2030)

3.5.3 Europe Autoimmune Drugs Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Autoimmune Drugs Market Facts & Figures by Country

3.6.1 Asia Pacific Autoimmune Drugs Market Size by Country: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Autoimmune Drugs Sales by Country (2019-2030)

3.6.3 Asia Pacific Autoimmune Drugs Revenue by Country (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Autoimmune Drugs Market Facts & Figures by Country

3.7.1 Latin America Autoimmune Drugs Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Autoimmune Drugs Sales by Country (2019-2030)

3.7.3 Latin America Autoimmune Drugs Revenue by Country (2019-2030)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Autoimmune Drugs Market Facts & Figures by Country

3.8.1 Middle East and Africa Autoimmune Drugs Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Autoimmune Drugs Sales by Country (2019-2030)

3.8.3 Middle East and Africa Autoimmune Drugs Revenue by Country (2019-2030)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 U.A.E

4 Segment by Type

4.1 Global Autoimmune Drugs Sales by Type (2019-2030)

4.1.1 Global Autoimmune Drugs Sales by Type (2019-2024)

4.1.2 Global Autoimmune Drugs Sales by Type (2025-2030)

4.1.3 Global Autoimmune Drugs Sales Market Share by Type (2019-2030)

4.2 Global Autoimmune Drugs Revenue by Type (2019-2030)

4.2.1 Global Autoimmune Drugs Revenue by Type (2019-2024)

4.2.2 Global Autoimmune Drugs Revenue by Type (2025-2030)

4.2.3 Global Autoimmune Drugs Revenue Market Share by Type (2019-2030)

4.3 Global Autoimmune Drugs Price by Type (2019-2030)

5 Segment by Application

5.1 Global Autoimmune Drugs Sales by Application (2019-2030)

5.1.1 Global Autoimmune Drugs Sales by Application (2019-2024)

5.1.2 Global Autoimmune Drugs Sales by Application (2025-2030)

5.1.3 Global Autoimmune Drugs Sales Market Share by Application (2019-2030)

5.2 Global Autoimmune Drugs Revenue by Application (2019-2030)

5.2.1 Global Autoimmune Drugs Revenue by Application (2019-2024)

5.2.2 Global Autoimmune Drugs Revenue by Application (2025-2030)

5.2.3 Global Autoimmune Drugs Revenue Market Share by Application (2019-2030)

5.3 Global Autoimmune Drugs Price by Application (2019-2030)

6 Key Companies Profiled

6.1 Eli Lilly

6.1.1 Eli Lilly Corporation Information

6.1.2 Eli Lilly Description and Business Overview

6.1.3 Eli Lilly Autoimmune Drugs Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Eli Lilly Autoimmune Drugs Product Portfolio

6.1.5 Eli Lilly Recent Developments/Updates

6.2 GSK

6.2.1 GSK Corporation Information

6.2.2 GSK Description and Business Overview

6.2.3 GSK Autoimmune Drugs Sales, Revenue and Gross Margin (2019-2024)

6.2.4 GSK Autoimmune Drugs Product Portfolio

6.2.5 GSK Recent Developments/Updates

6.3 AbbVie

6.3.1 AbbVie Corporation Information

6.3.2 AbbVie Description and Business Overview

6.3.3 AbbVie Autoimmune Drugs Sales, Revenue and Gross Margin (2019-2024)

6.3.4 AbbVie Autoimmune Drugs Product Portfolio

6.3.5 AbbVie Recent Developments/Updates

6.4 Johnson & Johnson

6.4.1 Johnson & Johnson Corporation Information

6.4.2 Johnson & Johnson Description and Business Overview

6.4.3 Johnson & Johnson Autoimmune Drugs Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Johnson & Johnson Autoimmune Drugs Product Portfolio

6.4.5 Johnson & Johnson Recent Developments/Updates

6.5 Biogen

6.5.1 Biogen Corporation Information

6.5.2 Biogen Description and Business Overview

6.5.3 Biogen Autoimmune Drugs Sales, Revenue and Gross Margin (2019-2024)

6.5.4 Biogen Autoimmune Drugs Product Portfolio

6.5.5 Biogen Recent Developments/Updates

6.6 Amgen

6.6.1 Amgen Corporation Information

6.6.2 Amgen Description and Business Overview

6.6.3 Amgen Autoimmune Drugs Sales, Revenue and Gross Margin (2019-2024)

6.6.4 Amgen Autoimmune Drugs Product Portfolio

6.6.5 Amgen Recent Developments/Updates

6.7 Pfizer

6.6.1 Pfizer Corporation Information

6.6.2 Pfizer Description and Business Overview

6.6.3 Pfizer Autoimmune Drugs Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Pfizer Autoimmune Drugs Product Portfolio

6.7.5 Pfizer Recent Developments/Updates

6.8 Roche

6.8.1 Roche Corporation Information

6.8.2 Roche Description and Business Overview

6.8.3 Roche Autoimmune Drugs Sales, Revenue and Gross Margin (2019-2024)

6.8.4 Roche Autoimmune Drugs Product Portfolio

6.8.5 Roche Recent Developments/Updates

6.9 Baxter

6.9.1 Baxter Corporation Information

6.9.2 Baxter Description and Business Overview

6.9.3 Baxter Autoimmune Drugs Sales, Revenue and Gross Margin (2019-2024)

6.9.4 Baxter Autoimmune Drugs Product Portfolio

6.9.5 Baxter Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Autoimmune Drugs Industry Chain Analysis

7.2 Autoimmune Drugs Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Autoimmune Drugs Production Mode & Process

7.4 Autoimmune Drugs Sales and Marketing

7.4.1 Autoimmune Drugs Sales Channels

7.4.2 Autoimmune Drugs Distributors

7.5 Autoimmune Drugs Customers

8 Autoimmune Drugs Market Dynamics

8.1 Autoimmune Drugs Industry Trends

8.2 Autoimmune Drugs Market Drivers

8.3 Autoimmune Drugs Market Challenges

8.4 Autoimmune Drugs Market Restraints

9 Research Finding and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Global Autoimmune Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Autoimmune Drugs Market Value Comparison by Application (2024-2030) & (US$ Million)

Table 3. Global Autoimmune Drugs Market Competitive Situation by Manufacturers in 2023

Table 4. Global Autoimmune Drugs Sales (K Units) of Key Manufacturers (2019-2024)

Table 5. Global Autoimmune Drugs Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Autoimmune Drugs Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Autoimmune Drugs Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Autoimmune Drugs Average Price (USD/Unit) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Autoimmune Drugs, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Autoimmune Drugs, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Autoimmune Drugs, Product Type & Application

Table 12. Global Key Manufacturers of Autoimmune Drugs, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Autoimmune Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Autoimmune Drugs as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Autoimmune Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Autoimmune Drugs Sales by Region (2019-2024) & (K Units)

Table 18. Global Autoimmune Drugs Sales Market Share by Region (2019-2024)

Table 19. Global Autoimmune Drugs Sales by Region (2025-2030) & (K Units)

Table 20. Global Autoimmune Drugs Sales Market Share by Region (2025-2030)

Table 21. Global Autoimmune Drugs Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Autoimmune Drugs Revenue Market Share by Region (2019-2024)

Table 23. Global Autoimmune Drugs Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Autoimmune Drugs Revenue Market Share by Region (2025-2030)

Table 25. North America Autoimmune Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Autoimmune Drugs Sales by Country (2019-2024) & (K Units)

Table 27. North America Autoimmune Drugs Sales by Country (2025-2030) & (K Units)

Table 28. North America Autoimmune Drugs Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Autoimmune Drugs Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Autoimmune Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Autoimmune Drugs Sales by Country (2019-2024) & (K Units)

Table 32. Europe Autoimmune Drugs Sales by Country (2025-2030) & (K Units)

Table 33. Europe Autoimmune Drugs Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Autoimmune Drugs Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Autoimmune Drugs Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Autoimmune Drugs Sales by Region (2019-2024) & (K Units)

Table 37. Asia Pacific Autoimmune Drugs Sales by Region (2025-2030) & (K Units)

Table 38. Asia Pacific Autoimmune Drugs Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Autoimmune Drugs Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Autoimmune Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Autoimmune Drugs Sales by Country (2019-2024) & (K Units)

Table 42. Latin America Autoimmune Drugs Sales by Country (2025-2030) & (K Units)

Table 43. Latin America Autoimmune Drugs Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Autoimmune Drugs Revenue by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Autoimmune Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East & Africa Autoimmune Drugs Sales by Country (2019-2024) & (K Units)

Table 47. Middle East & Africa Autoimmune Drugs Sales by Country (2025-2030) & (K Units)

Table 48. Middle East & Africa Autoimmune Drugs Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa Autoimmune Drugs Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Autoimmune Drugs Sales (K Units) by Type (2019-2024)

Table 51. Global Autoimmune Drugs Sales (K Units) by Type (2025-2030)

Table 52. Global Autoimmune Drugs Sales Market Share by Type (2019-2024)

Table 53. Global Autoimmune Drugs Sales Market Share by Type (2025-2030)

Table 54. Global Autoimmune Drugs Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Autoimmune Drugs Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Autoimmune Drugs Revenue Market Share by Type (2019-2024)

Table 57. Global Autoimmune Drugs Revenue Market Share by Type (2025-2030)

Table 58. Global Autoimmune Drugs Price (USD/Unit) by Type (2019-2024)

Table 59. Global Autoimmune Drugs Price (USD/Unit) by Type (2025-2030)

Table 60. Global Autoimmune Drugs Sales (K Units) by Application (2019-2024)

Table 61. Global Autoimmune Drugs Sales (K Units) by Application (2025-2030)

Table 62. Global Autoimmune Drugs Sales Market Share by Application (2019-2024)

Table 63. Global Autoimmune Drugs Sales Market Share by Application (2025-2030)

Table 64. Global Autoimmune Drugs Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Autoimmune Drugs Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Autoimmune Drugs Revenue Market Share by Application (2019-2024)

Table 67. Global Autoimmune Drugs Revenue Market Share by Application (2025-2030)

Table 68. Global Autoimmune Drugs Price (USD/Unit) by Application (2019-2024)

Table 69. Global Autoimmune Drugs Price (USD/Unit) by Application (2025-2030)

Table 70. Eli Lilly Corporation Information

Table 71. Eli Lilly Description and Business Overview

Table 72. Eli Lilly Autoimmune Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 73. Eli Lilly Autoimmune Drugs Product

Table 74. Eli Lilly Recent Developments/Updates

Table 75. GSK Corporation Information

Table 76. GSK Description and Business Overview

Table 77. GSK Autoimmune Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 78. GSK Autoimmune Drugs Product

Table 79. GSK Recent Developments/Updates

Table 80. AbbVie Corporation Information

Table 81. AbbVie Description and Business Overview

Table 82. AbbVie Autoimmune Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 83. AbbVie Autoimmune Drugs Product

Table 84. AbbVie Recent Developments/Updates

Table 85. Johnson & Johnson Corporation Information

Table 86. Johnson & Johnson Description and Business Overview

Table 87. Johnson & Johnson Autoimmune Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 88. Johnson & Johnson Autoimmune Drugs Product

Table 89. Johnson & Johnson Recent Developments/Updates

Table 90. Biogen Corporation Information

Table 91. Biogen Description and Business Overview

Table 92. Biogen Autoimmune Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 93. Biogen Autoimmune Drugs Product

Table 94. Biogen Recent Developments/Updates

Table 95. Amgen Corporation Information

Table 96. Amgen Description and Business Overview

Table 97. Amgen Autoimmune Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 98. Amgen Autoimmune Drugs Product

Table 99. Amgen Recent Developments/Updates

Table 100. Pfizer Corporation Information

Table 101. Pfizer Description and Business Overview

Table 102. Pfizer Autoimmune Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 103. Pfizer Autoimmune Drugs Product

Table 104. Pfizer Recent Developments/Updates

Table 105. Roche Corporation Information

Table 106. Roche Description and Business Overview

Table 107. Roche Autoimmune Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 108. Roche Autoimmune Drugs Product

Table 109. Roche Recent Developments/Updates

Table 110. Baxter Corporation Information

Table 111. Baxter Description and Business Overview

Table 112. Baxter Autoimmune Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 113. Baxter Autoimmune Drugs Product

Table 114. Baxter Recent Developments/Updates

Table 115. Key Raw Materials Lists

Table 116. Raw Materials Key Suppliers Lists

Table 117. Autoimmune Drugs Distributors List

Table 118. Autoimmune Drugs Customers List

Table 119. Autoimmune Drugs Market Trends

Table 120. Autoimmune Drugs Market Drivers

Table 121. Autoimmune Drugs Market Challenges

Table 122. Autoimmune Drugs Market Restraints

Table 123. Research Programs/Design for This Report

Table 124. Key Data Information from Secondary Sources

Table 125. Key Data Information from Primary Sources

List of Figures

Figure 1. Product Picture of Autoimmune Drugs

Figure 2. Global Autoimmune Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Autoimmune Drugs Market Share by Type in 2023 & 2030

Figure 4. Rheumatoid Arthritis (RA) Product Picture

Figure 5. Multiple Sclerosis (MS) Product Picture

Figure 6. Psoriasis Product Picture

Figure 7. Inflammatory Bowel Disease (IBD) Product Picture

Figure 8. Ankylosing Spondylitis (AS) Product Picture

Figure 9. Systemic Lupus Erythematosus (SLE) Product Picture

Figure 10. Global Autoimmune Drugs Market Value Comparison by Application (2024-2030) & (US$ Million)

Figure 11. Global Autoimmune Drugs Market Share by Application in 2023 & 2030

Figure 12. Hospitals

Figure 13. Homecare

Figure 14. Specialty Clinics

Figure 15. Global Autoimmune Drugs Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 16. Global Autoimmune Drugs Market Size (2019-2030) & (US$ Million)

Figure 17. Global Autoimmune Drugs Sales (2019-2030) & (K Units)

Figure 18. Global Autoimmune Drugs Average Price (USD/Unit) & (2019-2030)

Figure 19. Autoimmune Drugs Report Years Considered

Figure 20. Autoimmune Drugs Sales Share by Manufacturers in 2023

Figure 21. Global Autoimmune Drugs Revenue Share by Manufacturers in 2023

Figure 22. The Global 5 and 10 Largest Autoimmune Drugs Players: Market Share by Revenue in 2023

Figure 23. Autoimmune Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023

Figure 24. Global Autoimmune Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 25. North America Autoimmune Drugs Sales Market Share by Country (2019-2030)

Figure 26. North America Autoimmune Drugs Revenue Market Share by Country (2019-2030)

Figure 27. U.S. Autoimmune Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 28. Canada Autoimmune Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 29. Europe Autoimmune Drugs Sales Market Share by Country (2019-2030)

Figure 30. Europe Autoimmune Drugs Revenue Market Share by Country (2019-2030)

Figure 31. Germany Autoimmune Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 32. France Autoimmune Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 33. U.K. Autoimmune Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 34. Italy Autoimmune Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 35. Russia Autoimmune Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 36. Asia Pacific Autoimmune Drugs Sales Market Share by Region (2019-2030)

Figure 37. Asia Pacific Autoimmune Drugs Revenue Market Share by Region (2019-2030)

Figure 38. China Autoimmune Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. Japan Autoimmune Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. South Korea Autoimmune Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. India Autoimmune Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 42. Australia Autoimmune Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 43. Taiwan Autoimmune Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 44. Indonesia Autoimmune Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 45. Thailand Autoimmune Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 46. Malaysia Autoimmune Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 47. Philippines Autoimmune Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 48. Latin America Autoimmune Drugs Sales Market Share by Country (2019-2030)

Figure 49. Latin America Autoimmune Drugs Revenue Market Share by Country (2019-2030)

Figure 50. Mexico Autoimmune Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 51. Brazil Autoimmune Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 52. Argentina Autoimmune Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 53. Middle East & Africa Autoimmune Drugs Sales Market Share by Country (2019-2030)

Figure 54. Middle East & Africa Autoimmune Drugs Revenue Market Share by Country (2019-2030)

Figure 55. Turkey Autoimmune Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 56. Saudi Arabia Autoimmune Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 57. U.A.E Autoimmune Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 58. Global Sales Market Share of Autoimmune Drugs by Type (2019-2030)

Figure 59. Global Revenue Market Share of Autoimmune Drugs by Type (2019-2030)

Figure 60. Global Autoimmune Drugs Price (USD/Unit) by Type (2019-2030)

Figure 61. Global Sales Market Share of Autoimmune Drugs by Application (2019-2030)

Figure 62. Global Revenue Market Share of Autoimmune Drugs by Application (2019-2030)

Figure 63. Global Autoimmune Drugs Price (USD/Unit) by Application (2019-2030)

Figure 64. Autoimmune Drugs Value Chain

Figure 65. Autoimmune Drugs Production Process

Figure 66. Channels of Distribution (Direct Vs Distribution)

Figure 67. Distributors Profiles

Figure 68. Bottom-up and Top-down Approaches for This Report

Figure 69. Data Triangulation

Figure 70. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-2316

Fri Mar 21 00:00:00 UTC 2025

$8000

Enterprise User

Add to Cart

Global Bilirubin Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

120 Pages

Type: Report

Code: QYRE-Auto-35U2436

Fri Mar 21 00:00:00 UTC 2025

$8000

Enterprise User

Add to Cart

Global Intracardiac Echocardiography Catheter Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-7J13314

Fri Mar 21 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global End Stage Renal Disease Treatment Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-2F6212

Fri Mar 21 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Autoimmune Drugs Market Research Report 2024

Published Date: February 2024

Report Code: QYRE-Auto-37K9641

Global Autoimmune Drugs Market Research Report 2024

FEATURED COMPANIES

Autoimmune Drugs Market Size

Autoimmune Drugs Market

Report Scope

Scope of Autoimmune Drugs Market Report

Chapter Outline

FAQ for this report

How fast is Autoimmune Drugs Market growing?

What is the Autoimmune Drugs Market size in 2030?

Who are the main players in the Autoimmune Drugs Market report?

What are the Application segmentation covered in the Autoimmune Drugs Market report?

What are the Type segmentation covered in the Autoimmune Drugs Market report?

FEATURED COMPANIES

RELATED REPORTS

$8000

Enterprise User

$8000

Enterprise User

$5800

Enterprise User

$5800

Enterprise User

Global Webtoons Market Insights and Forecast to 2028

Single User, Electronic (PDF)